New European guidelines for cardiovascular disease prevention in clinical practice

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 2, 2009, Pages 138-142

  De Backer, Guy ^a,b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cardiovascular disease; Guidelines; Prevention; Risk factors

Indexed keywords

CARDIOVASCULAR AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONFERENCE PAPER; EUROPE; HEART PROTECTION; HIGH RISK PATIENT; HUMAN; LIFESTYLE MODIFICATION; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT; SCORING SYSTEM; SEX DIFFERENCE; SMOKING;

CARDIOVASCULAR DISEASES; EUROPE; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 59849086361     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.038     Document Type: Conference Paper

References (9)

1. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007;14(Suppl 2):S1-88.
2. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2007;28:2375-414.
3. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Atherosclerosis 2007;194:1-45.
4. Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and the European Society of Hypertension. Atherosclerosis 1994;110:121-61.
5. EuroAspire I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention guidelines: a comparison of EuropAspire I and II in nine countries. Lancet 2001;357:995-1001.
6. EuroAspire II Study Group. Lifestyle and risk factor management and use of drug therapy in coronary patients from 15 countries. Eur Heart J 2001;22:554-72.
7. Conroy R, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
8. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2003;10(Suppl 1):S1-78.
9. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, prediabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J 2007;28:88-136.